In their Antitrust Trade and Practice column, Shepard Goldfein and James Keyte discuss the key issues the D.C. District Court is likely to consider in assessing the DOJ’s antitrust case against AT&T/Time Warner.
An investor in Innoviva Inc. has finally won its fight to appoint two directors to the drug developer's board, after the Chancery Court on Dec. 8 ruled that the company was bound to honor a last-minute deal to resolve a dramatic proxy fight.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.